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Antibiotic resistant infections are responsible for approximately 23,000 deaths every year 
in the United States alone. The formation of bacterial biofilms makes resistant bacteria 
difficult to eliminate completely using chemical treatment. Therefore, novel antimicrobial 
compounds such as amphiphiles are essential to slow or stop the spread of resistant 
bacteria. Several novel series of amphiphiles were synthesized, and discrete aspects of 
their chemical structure were altered to investigate the relationship between structure and 
antibacterial activity. Minimum inhibitory concentration (MIC) assays were used to 
measure antibacterial activity against two Gram-negative and five Gram-positive 
bacteria, and the most effective compounds were tested for biofilm disruption activity 
against Pseudomonas aeruginosa using a Crystal Violet assay.  For the tris-cationic M-
E,n,n; M-DMAP,n,n; M-IQ,n,n; and M-4PP,n,n series, twelve carbons per tail was the 
ideal tail length for antibacterial activity, having MIC values as low as 4-8 µM against 
Gram-negative species and 2-4 µM against Gram-positive species. The 12-carbon 
derivatives also disrupted up to 70% of established P. aeruginosa biofilms at 
concentrations comparable to tobramycin and benzalkonium chloride. Hofmeister 
counterion substitution of one single-tailed and one double-tailed compound (M-1,1,18 
and M-1,12,12, respectively) resulted in a notable 8-fold decrease in the MIC against P. 
aeruginosa when the bromide counterion was replaced with chloride, and a 16-fold 
decrease when the counterion was substituted with iodide. Finally, in order to determine 
the effect of charge distribution in the head group, three bis-cationic (oX-n,n; mX-n,n; 
and pX-n,n) and three tetra-cationic series (oX-(2,n)2; mX-(2,n)2; and pX-(2,n)2) of 
double-tailed amphiphiles of varying tail lengths were synthesized and tested for their 
x 
 
MIC values. For all three series of bis-cationic amphiphiles, as well as the mX-(2,n)2 and 
pX-(2,n)2 series, the 12-carbon derivatives had the lowest MIC values. However, the oX-
(2,n)2 series had an ideal tail length of 8 carbons per tail. This further understanding of 
the relationship between structure and function of antimicrobial amphiphiles can be used 
to create more effective disinfectants and antibiotics. Continuing research into novel 
antibacterial compounds and biofilm disrupting agents is essential to combat the growing 





Chapter 1. Introduction 
1.1 Antibiotic- and Disinfectant-Resistant Bacteria 
Bacteria that are resistant to commonly used antibiotics and disinfectants cause over 2 
million illnesses and 23,000 deaths each year in the United States alone (CDC, 2013). 
Several strains of resistant bacteria have emerged since the development of antibiotics.  
Staphylococcus aureus is well-known for its ability to resist killing by antibiotics, and 
Methicillin-resistant strains of S. aureus (MRSA) have been implicated in community-
acquired infections after decades of being historically limited to a healthcare settings 
(Chambers and DeLeo, 2009). Gram-negative bacteria can resist antibiotics by, among 
other methods, altering the makeup and permeability of their outer membrane (Sawai et 
al. 1979). Pseudomonas aeruginosa is a ubiquitous organism that has demonstrated 
resistance to certain compounds partly due to its ability to enzymatically break down 
these compounds after they enter the cell (Ali et al. 2015; Ma et al. 1998). Bacteria such 
as Escherichia coli further resist centimide and other antibiotics by forming highly 
resilient biofilms (Evans et al. 1990). 
The development of resistance can be affected – and often accelerated – by human 
activity. The overuse of antibiotics has been shown to lead to an increase in the incidence 
of highly resistant organisms, particularly in hospitals (Dancer et al. 2009). Resistance to 
some of the most effective antibiotics such as vancomycin and colistin, often used to treat 
highly resistant infections, has also recently begun to emerge (Liu et al. 2016; Cardile et 
al. 2015; Schrenk et al. 2015). Despite this increasing emergence of resistant infections, 
antibiotics continue to be overprescribed in the United States and worldwide. The 




including increases in the prescription of last-resort antibiotics such as polymixins and 
carbapenems (van Boeckel et al. 2014). Additionally, as many as 60% of the antibiotics 
prescribed in United States intensive care units may not be the optimal agent for 
eradication of the infection that is being treated, and the choice of treatment may be 
incorrect in as many as 50% of cases (CDC, 2013; Luyt et al. 2014). In fact, in many 
cases of infection, the causative agent is not positively identified at all (Bartlett et al. 
2013), increasing the risk of inappropriate therapy contributing to the development of 
resistance.  
The majority of antibiotics sold in the United States, however, are used in agriculture 
rather than in medicine in order to increase the growth and yield of domesticated animals 
(Bartlett et al. 2013). The first case of plasmid-mediated resistance to the last-resort 
antibiotic, colistin, carried on the mcr-1 gene, was traced back to the antibiotic’s use in 
Chinese pig farms as a growth promoting treatment (Liu et al. 2016). These resistant 
bacteria can reach consumers through animal products such as meat (Bartlett et al. 2013), 
but can also be dispersed through secretion in urine and stool into groundwater and 
fertilizer (Bartlett et al. 2013; CDC 2013). The same gene has been found in multiple 
pathogenic bacteria such as Klebsiella pneumoniae (Nicolet et al. 2016) and E. coli 
(Poirel et al. 2016). The dispersal of resistance genes between different species and even 
genera or families leaves some pathogens unable to be treated with any known antibiotic. 
The widespread and inappropriate use of antibiotics has led to an increase the demand 
for novel antimicrobial compounds, particularly in hospital settings where resistant 
infections can spread rapidly within immunocompromised populations. These healthcare-




such as ventilators and catheters, and can be extremely difficult to treat due to several 
bacterial resistance genes and virulence factors that decrease susceptibility to common 
antibacterial agents (CDC, 2014). 
1.2 Biofilms and Transmission of Resistant Bacteria – Implications for Nosocomial 
Infection 
 Many diverse virulence factors may contribute to the resistance of pathogenic 
bacteria to eradication by standard antimicrobials, but one that is particularly significant 
to the spread of infections within hospitals is the formation of biofilms. A biofilm is a 
collection of bacterial cells that have adhered irreversibly to a surface within a 
heterogeneous extracellular polysaccharide matrix (Figure 1), which may compose as 
much as 90% of the organic material of the biofilm. Although the physical characteristics 
of the biofilm itself are highly variable, bacteria living within a biofilm tend to have a 
decreased metabolic rate, as well as 
increased resistance to antibacterial 
compounds and the host immune 
response (Donlan, 2002; Pawar et al. 
2015). In addition, bacteria within 
biofilms have also been shown to 
acquire new resistance at a faster 
rate than planktonic cells (Gillings et 
al. 2009). 
 Biofilm formation begins when bacteria attach at first reversibly, and later 
irreversibly, to a surface. At this stage, characteristics of the surface itself have significant 
Figure 1. Scanning electron microscope image of 
Staphylococcus aureus biofilm. Bacteria are surrounded by a 
web-like extracellular matrix which protects them from 
desiccation and chemical stressors. (Photo from the CDC Public 




influence on the rate of biofilm development, with rougher and more hydrophobic 
materials generally fostering more rapid growth (Fletcher et al. 1979; Quirynen et al. 
2000). Characteristics such as the presence of fimbriae (Rosenberg et al. 1982) or flagella 
(Korber et al. 1989) also affect the initial attachment of bacteria to surfaces during 
biofilm formation. Irreversibly attached cells form highly hydrated extracellular 
polysaccharides, forming a heterogeneous matrix that includes filter-like channels which 
transport nutrients throughout the biofilm (Lewandowski, 2000). 
Established biofilms are difficult to remove using established chemical cleaning 
protocols, often requiring extensive physical means of dispersal or harsh chemical 
sterilization for complete removal (Vickery et al. 2004, 2012; O’Donnell et al. 2005). 
Failure to completely remove these biofilms from hospital equipment such as catheters 
can contribute to nosocomial infection by providing a route of infection to an 
opportunistic pathogen. Cancer patients, for example, are particularly susceptible to 
Staphylococcus infection through semi-permanent catheters such as peripherally inserted 
central catheter (PICC) lines (Schrenk et al. 2015). Endoscopes serve as a major route of 
nosocomial infection due to biofilm adherence; P. aeruginosa is often transmitted 
between patients following incomplete cleaning of endoscopes between procedures. 
However, although human error may contribute to a large portion of infection cases, even 
strict compliance with cleaning protocol has been found to result in roughly a 2% 
bacterial contamination rate in endoscopes deemed ready for use in patients (Vickery et 
al. 2004). Therefore, current decontamination procedures are unable to completely 
eradicate all biofilms or prevent transmission of infection between patients, even without 




P. aeruginosa and S. aureus, two opportunistic pathogens with high affinity for 
biofilm formation, are also associated with additional complications following surgery. 
Bacteria with higher capacity for biofilm formation tend to be associated with longer 
recovery time and more complications following endoscopic surgical procedures 
(Bendouah et al. 2006). S. aureus has also been implicated in cases of septic arthritis and 
graft failure following ligament reconstruction surgery, as well as surgical site and bone 
infections (Hiller et al. 2015; Wright and Nair, 2010; Humphreys et al. 2016). It is 
important to note, however, that S. aureus and even P. aeruginosa have been observed as 
part of the normal skin and nasal flora in healthy individuals, suggesting that other factors 
influence virulence in addition to high affinity for biofilm formation (Al-Shemari et al. 
2007). 
P. aeruginosa is a prominent pathogen in hospital settings, and is responsible for 
most cases of hospital-associated pneumonia (Brewer et al. 1996, Richards et al. 1999). 
Pneumonia, along with 
surgical site infection, is one 
of the leading causes of 
morbidity and mortality 
associated with nosocomial 
infection (CDC, 2014; Figure 
2). Additionally, P. 
aeruginosa is highly resistant 
to many disinfectant 
compounds largely due to its 
Pneumonia 
157,500 













Figure 2. Type distribution of reported nosocomial infections in the 




production of efflux pumps and β-lactamases (Li et al. 1994). Contamination of hospital 
equipment such as ventilators and endoscopes can increase hospital-associated morbidity 
and mortality by fostering the spread of bacteria between patients, causing infections 
such as ventilator-associated pneumonia (VAP; Brewer et al. 1996). 
Another prominent cause of nosocomial infection is Escherichia coli, which, 
along with P. aeruginosa and Enterococcus species such as E. faecalis and E. faecium, is 
one of the most common causes of bloodstream infections (Peleg, 2010, Olawale et al. 
2011). E. coli is also the most common Gram-negative species implicated in urinary tract 
infections associated with urethral catheters (Hidron et al. 2008), and uropathogenic 
strains possess a variety of virulence factors aiding in persistence and infection, including 
several associated with biofilm formation (Jacobsen et al. 2008).  
Streptococcus agalactiae, also commonly known as Group B streptococcus, is 
associated with severe meningitis in newborns, with onset possible as early as within one 
week of birth, or as late as 3 months of age (Guiltbert et al. 2010). Although nosocomial 
transmission has been mostly attributed to limited contamination by medical workers, 
rare outbreaks have occurred where no common health care workers could be identified, 
and were linked to environmental reservoirs within the neonatal intensive care unit 
(MacFarguhar et al. 2010).   
1.3 Antibacterial Development 
 Although the demand for antibiotic drugs is high, mof the world’s most prominent 
scientific funding agencies allocate very little grant money to antibiotic discovery and 




allocate only approximately 3.9% of total funds to antimicrobial resistance research 
(Head et al. 2013). In the United States, the NIH allocated slightly over 1% of its budget 
to antimicrobial resistance research, less than a tenth of what was allocated to 
biotechnology and a seventh of what was allocated to research into aging (NIH, 2016). 
 Additionally, the development of antibiotics with novel targets and mechanisms 
has slowed considerably. Two truly novel antibiotic classes with new microbial targets – 
daptomycin and linezolid – have been introduced in the past decade (IDSA, 2010; 2011).  
This is due in large part financial limitations, as research into antibiotics – which are 
relatively cheap and most often used short-term – is not viewed as economically 
profitable for pharmaceutical companies when compared to research into other drugs for 
chronic health conditions (Piddock, 2012; Bartlett et al. 2013). Additionally, regulatory 
barriers prevent the rapid delivery of novel drugs to market. Implementation of new drugs 
can take up to 2 decades from drug discovery to use in the general public (Figure 3). This 
is in part because human trials comparing the efficacy of new compounds to a placebo 
are often considered unethical, and so studies must rely on comparisons to existing 
antibiotics, necessitating large sample sizes and therefore high cost (Wright and Nair, 
2014). 
  
Figure 3. Timeline of novel drug discovery and development. Novel drug development can take up to 
2 decades to complete, and involve proving safety and efficacy in humans before reaching the 




One promising area of study is in the activity of antimicrobial peptides (AMPs), 
which are short, positively charged, amphiphilic amino acid chains produced by a wide 
array of organisms as part of the innate immune response (Jenssen et al. 2006). These 
peptides have broad-spectrum antibacterial activity, affecting the bacterial cytoplasmic 
membrane and causing depolarization and cell lysis (Hancock and Rozek, 2002). The 
bactericidal activity of these peptides relies on both the charge of the molecule and 
hydrophobic interactions for insertion into the membrane (Dathe and Wieprecht, 1999). 
Many bacteria remain sensitive to killing by AMPs despite frequent exposure to these 
peptides, likely due to the fact that many mutations conferring resistance to AMPs require 
a high metabolic cost (Nizet, 2006). Despite the broad spectrum of efficacy of AMPs, the 
widespread implementation of AMPs in a clinical setting is limited by the high cost of 
large-scale AMP production (Marr et al. 2006; Findlay et al. 2010). The development of 
wholly synthetic AMPs provides a potential way to circumvent the high cost of AMP 
production, and amphiphilic AMP mimics lacking natural amino acids still have broad-
spectrum antibacterial activity against both Gram-negative and Gram-positive organisms 
(Mowery et al. 2007; Scott et al. 2008). Quaternary ammonium compounds are simple 
amphiphilic mimics of AMPs that are easier to produce, but still retain broad-spectrum 
antibacterial and anti-biofilm activity (Jennings et al. 2014). 
1.4 Amphiphiles  
Amphiphiles are compounds that possess both a hydrophobic and a hydrophilic 
portion on a single molecule (LaDow et al. 2011; Figure 4). The hydrophilic portion of 
the molecule is charged, and cationic (positively-charged) amphiphiles have been the 




the negatively charged extracellular 
matrix produced by bacteria (Jennings 
et al. 2014). Such interactions would 
likely be species-independent and 
broad-spectrum, allowing for a wide 
range of uses. Additionally the sheer 
number of possible structures available would promote a higher diversity of effective 
compounds to protect against the development of resistance resulting from the overuse of 
any single compound.  
The antibacterial activity of these types of compounds was first noted in 1935, 
and they are still commonly used as disinfecting agents and detergents (Gerhard, 1935). 
Amphiphiles have a wide array of possible structures, and some of the most promising 
are quaternary ammonium compounds (Forman et al, 2016). Ample research exists 
investigating the relationship between amphiphile structure and antibacterial activity 
(LaDow et al. 2011; Marafino et al. 2015; Song et al. 2011; Palermo et al. 2009).  
Previous studies have provided information about the effect of cationic head group 
substitution and hydrophobic hydrocarbon chain length on the minimum inhibitory 
concentration (MIC) of certain compounds on bacteria including P. aeruginosa and S. 
aureus. Structural changes such as hydrocarbon tail length variation, tail symmetry, and 
changes in the charge and structure of the hydrophilic region have been studied for their 
effects on antibacterial activity (Marafino et al. 2015; LaDow et al. 2011; Paniak et al. 
2014). In particular, the size of the hydrophobic region appear to be the strongest 
indicator of membrane permeability and antibacterial activity, with changes in the charge 
Hydrophobic Hydrophilic 
Figure 4. Generic amphiphile structure, including the 
hydrophilic head group (blue) and the hydrophobic 




and size of the hydrophilic region having less of an effect on the effectiveness of QACs 
(Paniak et al. 2014). 
Cationic amphiphiles interact strongly with the negatively charged phospholipids 
that make up 20-25% of the membrane (Glukov et al. 2005). The primary mechanism of 
action of these amphiphiles is disruption of the bacterial cell membrane, leading to 
disruption of transport proteins and proton motive force, cell lysis and death (Hoque et al. 
2012; Thiyagarajan et al. 2014; Ladow et al. 2011). As the lipid membrane is ubiquitous 
and energetically costly to repair, QACs offer broad-spectrum efficacy and little potential 
for the development of total resistance (Vudumula et al. 2012). This is particularly 
promising for the treatment of Gram-negative pathogens, whose additional outer 
membrane can decrease their susceptibility to several antibiotics unable to pass through 
the additional barrier (Bola et al. 2011). 
The biofilm disruption capabilities of amphiphilic compounds have also been the 
focus of a large amount of research. Previous work has suggested that amphiphilic 
polymers containing amide side chains are not only effective bactericidal agents against 
antibiotic-resistant strains of bacteria such as MRSA and vancomycin-resistant 
Enterococcus faecium (VRE), but were also more effective at disrupting both non-
resistant and multidrug-resistant Acinetobacter baumanii biofilms than established 
antibiotics such as erythromycin, tobramycin, and colistin (Uppu et al. 2016). 
Amphiphiles with different structures, including QACs, have also exhibited biofilm-
disruption activity. The likely mechanism of action of biofilm disruption by these 




compounds to lyse the planktonic cells released from the biofilm, leading to biofilm 
disruption due to the death of bacterial cells (Jennings et al. 2014). 
 
1.5 Amphiphiles Used in the Current Study 
Head group substitution and hydrocarbon tail length variation 
Four series of double tailed tris-
cationic amphiphiles were 
synthesized by the Caran lab (James 
Madison University). For each 
series, the amphiphiles consisted of a 
mesitylene core (M) with three 
attached positively charged head 
groups. Two of these head groups 
were dimethylalkylammonium 
groups with attached hydrocarbon 
tails. The third head group was either 
dimethylethanolammonium for the 
M-E,n,n series, 
dimethylaminopyridinium for the M-
DMAP,n,n series, isoquinolinium for 
the M-IQ,n,n series, and 4-propanol pyridinium  for the M-4PP,n,n series. The 
hydrocarbon tails were linear and symmetrical, and consisted of 8-16 carbons each for the 
M-E,n,n series 
n = 8,10,12,14,16 
M-DMAP,n,n series 
n = 10,12,14,16 
M-IQ,n,n series 
n = 10,12 
M-4PP,n,n series 
n = 10,12,14 
Figure 5. Structure of amphiphiles. M represents the Mesitylene 
core; n represents the number of carbons in each symmetrical 
hydrocarbon tail. E = dimethylethanolammonium, DMAP = 
dimethylaminopryidinium, IQ = isoquinolinium, and 4PP = 4-




M-E,n,n series, 10-16 carbons each for the M-DMAP,n,n series, 10-12 carbons each for 
the M-IQ series, and 10-14 carbons each for the M-4PP,n,n seres (Figure 5).  
 
Counterion exchange 
Two tris-cationic amphiphiles were synthesized by the Caran lab in order to determine 
the effects of counterion substitution on antibacterial activity. One single-tailed 
compound (M-1,1,18) and one double-tailed compound (M-1,12,12), which have both 
been previously studied (Marafino et al 2015), were used. Both compounds consisted of 
three positively charged dimethylalkylammonium residues attached to a mesitylene core, 
with a linear 18-carbon chain attached to one of these groups in M-1,1,18, and a linear 
12-carbon chain attached to each of two of the groups in M-1,12,12 (Figure 6). The 
standard bromide counterions 
were substituted with 
carbonate, acetate, nitrate, 
chloride, or iodide for M-
1,1,18, and substituted with 
acetate, chloride, or iodide for 
M-1,12,12. The structure of the 
amphiphiles themselves was 
not changed with these 
substitutions.    
Spacer variation and hydrocarbon tail length variation 
M-1,1,n series + 
Hofmeister 
counterion 
n = 18 
M-1,n,n series + 
Hofmeister 
counterion 
n = 12 
Figure 6. Structure of amphiphiles. M represents the Mesitylene core; 
n represents the number of carbons in each symmetrical hydrocarbon 
tail. X- represents the Hofmeister counterion in solution with the 




Three series of bis-cationic and three series of tetra-cationic double-tailed amphiphiles 
were synthesized by the Caran lab in order to determine the effects of varied placement 
of the headgroups and tails on the central mesitylene ring. The bis-cationic oX-, mX-, and 
pX-n,n series consisted of two dimethylalkylammonium residues attached to the central 
ring in either the ortho (oX-n,n series), meta (mX-n,n series) or para orientation (pX,n,n 
series). One linear hydrocarbon chain was attached to each of the two 
dimethylalkylammonium groups, and contained 8-14 carbons for the oX-n,n series, 8-12 
carbons for the mX-n,n series, and 8-16 carbons for the pX-n,n series (Figure 7). 
 
The tetra-cationic amphiphile series were structured similarly, however two 
dimethylalkylammonium head groups were attached to each of the same positions on the 
central ring, connected by a 2-carbon linker. The linear hydrocarbon tail connected to the 
head group in each of the tetra-cationic series contained 8-12 carbons for the oX-, mX-, 
and pX-(2,n)2 series (Figure 8).  
oX-n,n series 
n = 8,10,12,14 
mX-n,n series 
n = 8,10,12 
pX-n,n series 
n = 8,10,12,14,16 
Figure 7. Structure of bis-cationic amphiphiles. n represents the number of 
carbons in each symmetrical hydrocarbon tail. oX = ortho-orientation; mX 






One series of amphiphiles was synthesized by the Caran lab including 6 total 
dimethylalkylammonium head groups and three linear hydrocarbon tails of 8, 10, or 12 
carbons in length (Figure 9). The hexa-cationic M-(2,n)3 series was tested for its 
antibacterial activity with tail length variation. 
 The final compound synthesized by the Caran lab was 10-14-AO, a mono-cationic 
fluorescent compound derived from acridine orange that included a single 14-carbon tail 
(Figure 10). 
Figure 8. Structure of tetra-cationic amphiphiles. n represents the number of carbons in 
each symmetrical hydrocarbon tail. oX = ortho-orientation; mX = meta-orientation; pX = 
para-orientation.  
oX-(2,n)2 series 
n = 10,12,14 
mX-(2,n)2 series 
n = 10,12,14 
pX-(2,n)2 series 




   
Figure 9. Structure of the 6-headed, 
triple-tailed M-(2,n)3 series. n 
represents the number of carbons per 
tail (8,10,12). 
Figure 10. Structure of the fluorescent 




Chapter 2: The effect of tail length variation and head group substitution on 
minimum inhibitory concentration and biofilm disruption. 
2.1 Introduction.  
Bacteria that are resistant to commonly used antibiotics and disinfectants cause 
over 2 million illnesses and 23,000 deaths each year in the United States alone (CDC, 
2013). The development of resistance can be affected – and often accelerated – by human 
activity. The overuse of frequently used antibiotics has led to an increase in the incidence 
of highly resistant organisms, particularly in hospitals (Dancer et al. 2009). Resistance to 
powerful antibiotics such as vancomycin and colistin, often used to treat highly resistant 
infections, has also recently emerged (Liu et al. 2016; Cardile et al. 2015; Schrenk et al. 
2015).  
The accelerated development of resistance in ubiquitous organisms has 
contributed to the increased prevalence of nosocomial infections, which spread rapidly 
within immunocompromised populations often found in hospitals and nursing homes 
(Johnston and Bryce, 2009). Nosocomial infections such as pneumonia, bloodstream 
infections, and urinary tract infections are responsible for approximately 75,000 patient 
deaths every year (Magill et al. 2014) and place a significant economic burden on the 
United States healthcare system (CDC, 2013). Gram-negative bacteria can further resist 
antibiotics by altering the makeup and permeability of their outer membrane in addition 
to having other adaptations for resistance (Sawai et al. 1979). Pseudomonas aeruginosa is 
a ubiquitous organism that has demonstrated resistance to certain compounds partly due 
to its ability to enzymatically break down these compounds after they enter the cell (Ali 




antibiotics by forming biofilms (Evans et al. 1990). The development of novel 
antibacterial compounds is essential to curb the spread of resistant infections between 
patients and to reduce hospital-associated morbidity and mortality.   
Amphiphiles are a diverse class of compounds with well-documented 
antibacterial effects (Marafino et al. 2015; Ladow et al. 2011; Goswami et al. 2015; 
Thiyagarajan et al. 2014; Song et al. 2011). The antibacterial activity of these compounds 
was first noted in 1935, and they are still commonly used as disinfecting agents and 
detergents (Gerhard, 1935). Amphiphiles have a wide array of possible structures, and 
some of the most promising are quaternary ammonium compounds, which are molecules 
containing positively charged nitrogen residues (Forman et al. 2016). In addition to the 
charged hydrophilic head group, amphiphiles also contain a hydrophobic portion, usually 
consisting of one or more hydrocarbon tails. Structural changes such as hydrocarbon tail 
length variation, symmetry, and changes in the charge and structure of the hydrophilic 
region have been studied for their effects on antibacterial activity (Marafino et al. 2015; 
Ladow et al. 2011; Paniak et al. 2014). In particular, the size of the hydrophobic region 
appear to be the strongest indicator of membrane penetration and antibacterial activity, 
with changes in the charge and size of the hydrophilic region having less of an effect on 
the effectiveness of QACs (Paniak et al. 2014). Increased understanding of the effects of 
amphiphile structure on bactericidal activity is essential for the development of more 
effective antibacterial compounds.  
Four novel series of amphiphiles were synthesized, and the antibacterial effect of 
changes in head group structure and tail length was determined. All four series consisted 




head groups were dimethylalkylammonium groups, each connected to a linear 
hydrocarbon tail. The hydrocarbon tails were symmetrical and ranged in length from 8-16 
carbons for the M-E series, 10-16 carbons for the M-DMAP series, 10-12 carbons for the 
M-IQ series, and 10-14 carbons for the M-4PP series. The third head groups were an 
dimethylethanolammonium (M-E series), dimethylaminopyridinium (M-DMAP series), 
isoquinolinium (M-IQ series), or 4-propanol pyridinium  (M-4PP series; Figure 5).  
2.2 Results and Discussion. 
Critical Aggregation Concentration 
 The critical aggregation concentration (CAC) refers to the concentration at which 
the molecules aggregate in solution. Below the CAC, the amphiphile tends to behave as a 
monomer, while above the CAC, the amphiphile behaves as a micelle. The CAC was 
determined for the 10-16 carbon chain length derivatives of the M-E series. Consistent 
with previous studies of amphiphiles with similar structures (Marafino et al. 2015), the 
CAC decreases with increasing tail lengths, suggesting that a longer pair of hydrophobic 






Information about the CAC can also be used to determine more about the 
mechanism of action of these compounds, namely whether they act as monomers to exert 
a bacteriocidal effect, or if they act more similarly to detergents (as micelles). Because 
the MIC of all of the M-E series derivatives tested was below the CAC (Table 1, Table 
2), it is likely that these compounds are acting as monomers at bactericidal 
concentrations, and do not have a mechanism of action similar to detergents. This 
supports previous research on similar compounds, where tris-cationic double-tailed 
amphiphiles with trimethylammonium or pyridinium head groups also had MICs that fell 
far below their respective CAC values (Marafino et al. 2015). 
Minimum Inhibitory Concentration 
The minimum inhibitory concentration (MIC) was determined for two Gram-
negative bacterial species (P. aeruginosa and E. coli) and five Gram-positive species (S. 




















Total Carbons in Hydrophobic Tails 
Figure 11. Critical aggregation concentration for the 10, 12, 14, and 16 carbon 




all series (with only one exception) the MIC was lowest at a tail length of 12 carbons per 
tail. Above or below this optimal tail length, the MIC increased. This trend was observed 
for both Gram-negative and all Gram-positive bacteria tested. A similar trend was 
observed for all head group substitutions, with 12 carbons being the ideal tail length for 
structures with an dimethylethanolammonium, dimethylaminopyridinium, 
isoquinolinium, or 4-propanol pyridinium head group (Figure 12).   
The 12-carbon compound M-E,12,12 had MIC values ranging from 2-4 μM for 
Gram-positive bacteria, and 4-8 μM for Gram-negative bacteria. M-DMAP,12,12 had an 
MIC of 8 μM for both Gram-negative species, and MIC values ranging from 2-8 μM for 
Gram-positive species. MIC values for M-4PP,12,12 ranged from 2-4 μM for all bacteria 
tested, and those for M-IQ,12,12 ranged from 4-8 μM. Both M-4PP,12,12 and M-
IQ,12,12 were able to effectively inhibit the growth of P. aeruginosa at concentrations as 
low as 4 μM, a concentration comparable to the antibiotic tobramycin, an aminoglycoside 
widely used to treat chronic P. aeruginosa infection (Shawar et al. 1999).  
The trends observed for these compounds are consistent with previous research on 
structurally similar amphiphiles. Derivatives with two 12-carbon chains in the tail region 
have previously been reported to have lower MIC values than those with longer or shorter 







Table 1. MIC values for all compounds, benzalkonium chloride (BZK), and tobramycin. Values were 
confirmed with 2-3 independent experiments. X = head group (E = dimethylethanolammonium; DMAP = 
dimethylaminopyridinium; IQ = isoquinolinium; 4PP = 4-propanol pyridinium) and n = the number of 
carbons per tail. G+ = Gram-positive and G- = Gram-negative. 
 
 
Replacing the hydrophilic dimethylethanolammonium residue with 
dimethylaminopyridinium, isoquinolinium, or 4-propanol pyridinium  did not 
significantly change the trend in MIC. Other structurally similar 12-carbon derivatives 
with different head groups (trimethylammonium and pyridiunium) studied previously 
have had comparable antibacterial activity, further illustrating the effect of tail length on 
the efficacy of these double-tailed amphiphiles (Marafino et al. 2015). Taken together, 
these data suggest that substitution with equally charged head groups of comparable size 
does not have a considerable effect on antibacterial activity, and that tail length has a 
much larger effect on the ability of these compounds to inhibit bacterial growth.  
Compound 
(M-X,n,n) 















M-E,8,8 >250 >250 63 250 250 125 63 
M-E,10,10 250 125 4 125 16 4 4 
M-E,12,12 8 4 2 4 4 2 2 
M-E,14,14 125 8 4 8 8 4 8 
M-E,16,16 125 63 63 63 >250 >250 >250 
M-DMAP,10,10 63 63 8 63 16 8 4 
M-DMAP,12,12 8 8 2 4 8 2 2 
M-DMAP,14,14 16 16 4 4 8 4 4 
M-DMAP,16,16 250 31 8 16 16 8 8 
M-4PP,10,10 8 4 4 4 2 2 2 
M-4PP,12,12 4 2 4 2 2 4 2 
M-4PP,14,14 31 16 4 16 4 4 4 
M-IQ,10,10 125 8 4 8 8 4 8 
M-IQ,12,12 4 8 4 4 4 4 4 
BZK 8 31 8 16  2  




Structurally, these compounds are similar to benzalkonium chloride (BZK), a 
synthetic quaternary ammonium biocide with broad-spectrum antibacterial activity 
(Carson et al. 2008; Fazlara and Ekhtelat, 2012). Interestingly, all of the 12-carbon 
derivatives, as well as some 10- and 14-carbon derivatives tested have greater 
antibacterial activity than BZK against Gram-negative and Gram-positive species 
(Fazlara and Ekhtelat, 2012). 
All four series of tris-cationic, double-tailed amphiphiles presented in this study 
follow the previously illustrated trend suggesting a strong relationship between 
hydrocarbon tail length and antibacterial activity. Amphiphiles with 12 carbons in each 
symmetrical tail were the most effective at inhibiting all species of bacteria tested, 





Tail length (n for M-DMAP,n,n) 
Figure 12. The effect of tail length on antibacterial activity of the M-E,n,n; M-DMAP,n,n; M-IQ,n,n;, 
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Established P. aeruginosa biofilms were exposed to two-fold dilutions M-
E,12,12; M-DMAP,12,12; M-IQ,12,12; and M-4PP,12,12 . The percentage of biofilm 
disruption increased in a concentration-dependent manner from 2-63 µM for all 
amphiphiles tested, but at concentrations above 63 µM, increasing the compound 
concentration did not increase biofilm disruption. The amphiphiles tested disrupted a 
maximum of approximately 65% of established biofilm, with the exception of M-
4PP,12,12, which had a maximum disruption of approximately 40% (Figure 13). 
This disruption activity was compared to that of BZK and the aminoglycoside 
tobramycin. At similar concentrations, tobramycin disrupted approximately 66% of 
established biofilm, while BZK disrupted approximately 35-40% (Figure 13).  
Bacterial biofilms are commonly associated with greatly increased resistance to 
biocides due to the formation of a protective extracellular matrix and reduced metabolic 
rate of biofilm-associated cells (van der Veen and Abee, 2010; Costerton et al. 1999). 
Due to this increased resistance compared to planktonic cells, it is unsurprising that the 
concentration of biocide necessary to attain maximum biofilm disruption is several 






Figure 13. P. aeruginosa biofilm disruption by (A) M-E,12,12; (B) M-DMAP,12,12; 
(C) M-4PP,12,12; (D) M-IQ,12,12; (E) tobramycin and (F) BZK. Error bars represent 
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These data further support the relationship between solubility and antibacterial 
activity, suggesting that there is an ideal level of solubility that may maximize 
bactericidal efficiency. Of particular note are the MIC values of M-E,12,12; M-
DMAP,12,12; M-4PP,12,12; and M-IQ,12,12. These compounds are effective at 
inhibiting the growth of P. aeruginosa at concentrations as low as 4-8µM (Table 1). P. 
aeruginosa is a prominent pathogen in hospital settings, and is responsible for most cases 
of hospital-associated pneumonia (Brewer et al. 1996; Richards et al. 1999). 
Additionally, P. aeruginosa is highly resistant to many disinfectant compounds due to its 
semipermeable outer membrane and the production of efflux pumps and β-lactamases (Li 
et al. 1994). Contamination of hospital equipment such as ventilators and endoscopes can 
increase hospital-associated morbidity and mortality by fostering the spread of bacteria 
between patients, causing infections such as ventilator-associated pneumonia (VAP; 
Brewer et al. 1996). Four compounds mentioned effectively inhibit the growth of P. 
aeruginosa at concentrations comparable to the MIC of tobramycin, an antibiotic used to 
treat P. aeruginosa infection in cystic fibrosis patient (Oliver et al. 2000; Singh et al. 
2000; Vidya et al. 2016). Given this, as well as the fact that the MIC values of the most 
effective compounds were lower than those of the disinfectant, benzalkonium chloride, 
these compounds may prove useful in a hospital setting as novel disinfectants to prevent 
the spread of nosocomial infection due to P. aeruginosa. Because biofilm contributes to 
the spread and pathogenesis of P. aeruginosa, he potential for synergistic interaction 
between the compounds presented in this study and biofilm matrix-degrading enzymes 




Further research is needed to understand the mechanism of action of these 
compounds against bacterial biofilms, as it is uncertain whether they are actively 
interacting with the extracellular biofilm matrix or merely penetrating the matrix to target 
the bacterial cells embedded in the biofilm. The solubility and hydrophobicity of the EPS 
is highly variable, and it likely possesses localized hydrophilic and hydrophobic regions, 
making it unclear to what extent these amphiphiles are able to interact with the matrix 
effectively (Sutherland, 2001).  
 Given the increasing incidence of hospital acquired infection, particularly by 
highly resistant strains of bacteria, the need for novel antibacterial compounds is 
paramount, and understanding structure-function relationships of bactericidal molecules 
is necessary for the development of more effective disinfectants. Several compounds 
presented in this study show potential as novel disinfectants, either alone or in synergistic 
combination with other disinfecting agents or antibiotics. It is likely that these 
compounds behave similarly to other amphiphiles against planktonic cells by targeting 
the bacterial membrane (Goswami et al. 2015; Thiyagarajan et al. 2014; Song et al. 
2011). Gram-negative bacteria are particularly difficult to eradicate due to the presence of 
an outer membrane serving as a selectively permeable barrier to chemical stressors (Bolla 
et al. 2011). Membrane-permeabilizing agents, therefore, may lead to enhanced 
susceptibility to antibiotics not normally able to bypass this barrier. The results presented 
in this work provide information on the relationship between amphiphile structure and 
function, and may lead to the development of novel disinfecting agents that could 







A conductivity probe was used to measure the critical aggregate concentration of 
the amphiphile. The solution was heated to 37°C. The probe was mixed in the solution 
and the measurements were collected. Ten percent of the solution was pipetted out and 
replaced with nanopure water. The solution was mixed and the conductivity measurement 
recorded. These steps were repeated for the entirety of the experiment.  
Bacterial strains and growth conditions. 








, and the five Gram-positive 









, Bacillus subtilis, B. anthracis Sterne, 
and Streptococcus agalactiae J48 (Seifert et al. 2006). All strains were grown in 1x 
Mueller-Hinton Broth at 37° C for 12–24 h. For the MIC studies, bacterial suspensions 
were prepared by diluting overnight cultures to 5x10
6
 CFU/mL in 2X Mueller-Hinton 
Broth, so that when amphiphile solutions were added the final broth strength was 1X. 
Minimum inhibitory concentration. 
The methods used to determine the MIC were performed as previously described
 
and followed standards of the Clinical and Laboratory Standards Institute (Ladow et al. 
2011; CLSI, 2012). Briefly, compounds were serially diluted in sterile deionized water 
and 100µL of each dilution were added to the wells of a 96-well flat-bottomed microtiter 






the plates were incubated at 37°C for 72 h. The MIC of the compound was defined as the 
minimum concentration that resulted in visible inhibition of bacterial growth. 
Biofilm disruption 
 Biofilm disruption was determined as previously described (O’Toole, 2011). 
Briefly, 100µL of 5x10
6
 CFU/mL P. aeruginosa suspended in Luria Broth (LB) were 
added to a 96-well flat-bottomed microtiter plate. Plates were incubated at 37° C for 24 h 
to allow the biofilm to form. Sterile dI H2O served as a negative control for biofilm 
disruption, and 100µL of each dilution of the compounds were added in triplicate to the 
remaining wells. Plates were incubated at 37° C for another 24 h, after which the plates 
were emptied and rinsed with sterile dI water and allowed to dry. Wells were stained with 
100µL crystal violet, rinsed with gently running water, and allowed to dry. Finally, 
100µL of 95% ethanol was added to each well for 1 h. The ethanol-crystal violet solution 
was transferred to a fresh 96-well microtiter plate, and the absorbance value at 570 nm 






Chapter 3: The effect of Hoffmeister series counterion exchange on minimum 
inhibitory concentration of single- and double-tailed amphiphiles. 
3.1 Introduction. 
 Counterions accompany charged molecules in solution in order to maintain 
electric neutrality. These counterions can have an effect on several aspects of the 
interaction between molecules in solution, most notably on micellization of surfactants 
(Naskar  et al. 2012) . The self-assembly of amphiphiles in solution is a 
thermodynamically driven process that can be affected by differences in the hydrocarbon 
tail length and the charge and size of the hydrophilic head group. Ions in solution interact 
with the head group, and thereby have an effect on the assembly of monomers into 
micelles (Rosholm et al. 2010). These interactions are of particular interest to medicinal 
chemistry and drug discovery, since variation of the counterion paired with antibacterial 
compounds may affect antibacterial activity.  
Of particular interest are counterions from the well-studied Hofmeister series 
(Figure 14). The Hofmeister series was originally observed by Franz Hofmeister in 1888, 
and was reported to be a series of salts ordered according to their ability to precipitate 
proteins out of solution 
(Hofmeister, 1888; Kunz 
et al. 2004; Lo Nostro et 
al. 2012). More recently, 
ions in the Hofmeister 
series have been 
correlated with several 
Figure 14. Selected counterions from the Hofmeister used in this study, 
presented in order from strongly hydrated kosmotropes (left) to weakly 




chemical properties of amphiphiles in solution (Rosholm et al. 2010), as well as having a 
documented effect on the growth of both Gram-positive and negative bacteria including 
S. aureus and P. aeruginosa (Lo Nostro et al. 2005).  
Interestingly however, relatively little research has been done on the effects of 
Hofmeister series counterion substitution on the antibacterial activity of amphiphiles and 
similar membrane-active compounds. Therefore, the relationship between the known 
properties of Hofmeister series counterion exchange and amphiphile activity remains 
largely unknown.  
It was hypothesized that changes in micelle formation and aggregation due to 
counterion substitution could lead to a change in MIC correlated with the chemical 
changes associated with the Hofmeister series. Therefore, one single-tailed amphiphile 
(M-1,1,18) and one double-tailed amphiphile (M-1,12,12) were selected for counterion 
substitution (Figure 6). These amphiphiles were selected due to their low MIC values 
compared to other compounds with different hydrocarbon chain lengths in their 
respective series (Marafino et al. 2015). Counterions from the Hofmeister series were 
substituted for bromide (3Br
-
) without altering the structure of either amphiphile in order 
to determine whether counterion exchange on its own was sufficient to cause changes in 
MIC.  
3.2 Results and Discussion. 
Critical aggregation concentration 
 CAC, predictably, increased with increasing chaotropicity for single-tailed 
derivatives paired with different counterions in the Hofmeister series. When paired in 




approximately ten times lower than when paired with acetate, a more weakly hydrated 
kosmotrope (CAC table). 
Nitrogen-based cations such as those found in these amphiphiles have been categorized 
previously as largely chaotropic. Chaotropes interact most strongly with other chaotropes 
in solution, which may explain the decrease in CAC when M-1,1,18 was paired with 






Minimum inhibitory concentration 
Previously, all compounds tested in this study had bromide as the counterion; 
however, the effects of counterion substitution with other Hofmeister series anions had 
not been tested. Six Hofmeister anions (bromide, carbonate, acetate, nitrate, chloride, and 
iodide) were selected for counterion exchange with the single-tailed compound, M-1,1,18 
(Table 3). Substitution with carbonate, acetate, or nitrate resulted in slightly increased 
MIC values, particularly against Gram-positive bacteria, suggesting that these 
counterions may cause decreased bacteriocidal efficacy for this compound. Interestingly, 
while acetate and carbonate are both more kosmotrophic than bromide in the Hofmeister 
series, nitrate is more chaotrophic. It is likely that the change in antibacterial activity can 
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Table 2. CAC values of M-1,1,18 paired with 




therefore not be attributed to the chemical attributes of the Hofmeister series alone when 
these ions are paired with these antibacterial compounds.  
Chloride and iodide were also investigated as possible counterions for these 
amphiphiles. When paired with both of these anions, M-1,1,18 had much lower MIC 
values compared to M-1,1,18 paired with the other anions studied. Most notably, 
substitution with chloride and iodide resulted in a sixteen-fold and eight-fold decrease in 
MIC compared to bromide for P. aeruginosa, respectively, and an eight-fold decrease in 
MIC for S. aureus. While M-1,1,18 paired with bromide had an MIC of 125 µM against 
P. aeruginosa, the same compound was able to inhibit the growth of P. aeruginosa at 8 
µM when paired with chloride and at 16 µM when paired with iodide. Counterion 
exchanged M-1,1,18 paired with chloride and iodide were, with very few exceptions,  
more effective than M-1,1,18 paired with carbonate, acetate, or nitrate (Table 3).  
 
Despite notable changes in MIC with counterion exchange, no clear trend 
between Hofmeister series order and antibacterial activity was observed. The observed 
increase in CAC with increasing chaotropicity was not an accurate predictor of 
Counterion 
(M-1,1,18 + X) 

















125 16 4 16 4 2 4 
1.5 CO3
2- 
250 31 31 31 16 4 31 
3 C2H3O2
- 
250 63 16 63 31 4 31 
3 NO3
- 
250 63 16 31 16 4 31 
3 Cl
- 
8 16 8 2 2 4 2 
3 I
- 
16 8 16 2 16 4 8 
Table 3. MIC values of M-1,1,18 paired with six selected Hofmeister series anions (X): bromide, 
carbonate, acetate, nitrate, chloride, and iodide. Values were confirmed with 2-3 independent experiments. 




antibacterial activity. It is possible that other unknown factors, independent of Hofmeister 
series attributes, may contribute to antibacterial activity for these counterion exchanged 
amphiphiles, especially since somewhat different trends were observed for Gram-
negative versus Gram-positive species tested. 
To determine whether similar trends existed with counterion exchange for double-
tailed amphiphiles, the compound M-1,12,12 was paired with four different Hofmeister 
series anions: bromide, acetate, chloride, and iodide. Very little difference in MIC was 
observed for Gram-positive species, although M-1,12,12 paired with iodide did have 
lower MIC values compared with the compound paired with bromide. A four-fold 
decease in MIC was observed against P. aeruginosa for the chloride- and iodide-paired 
compound compared to the compound with bromide serving as the counterion. 
Interestingly, M-1,12,12 paired with acetate had similar antibacterial activity when 
compared with the compound with the chloride and iodide counterions, a trend that was 
not observed for the single-tailed M-1,1,18 (Table 3, Table 4). Once again, no clear trend 
relating the Hofmeister series to antibacterial activity of counterion exchanged 
compounds was observed, suggesting that other factors may influence changes in 
antibacterial activity than colloidal or chemical attributes of Hofmeister series anions 









Previous research has suggested that more chaotropic ions may be more effective 
at penetrating lipid monolayers than kosmotropic ions (Zhang and Cremer, 2006), and 
may suggest that direct interactions between the ions and the bacterial membrane itself 
may be at least partially responsible for the changes in MIC, in addition to interactions 
between the counterions and the amphiphiles in solution. Dissolved Hofmeister anions 
have also been shown to affect the absorption of cationic polyions onto hydrophobic 
surfaces. The addition of more kosmotrophic salts such as NaCl increase electrostatic 
screening and allow polycations to move closer to the interface with the hydrophobic 
surface. Chaotropic salts such as NaI allow for significant polycationic absorption at low 
concentrations, but the amount of polyion absorbed at the hydrophobic interface 
decreases with increasing concentrations due to increased electrostatic screening of the 
attraction between the anions and the polyelectrolytes (dos Santos and Levin, 2013). 
Although these findings were limited to simulation, they support the conclusion that 
chaotropic Hofmeister anions such as I
-
 may increase the efficiency of the interaction 
between the cationic hydrophilic head residue of these amphiphiles and the lipid 
membrane of bacteria. It is also important to note that this does not account for the 
Counterion 
(M-1,12,12 + X) 

















16 8 4 4 4 8  
3 C2H3O2
- 
4 4 4 4 4 8 2 
3 Cl
- 
2 4 4 4 2 8 2 
3 I
- 
2 8 2 2 2 2 2 
Table 4. MIC values of M-1,12,12 paired with four selected Hofmeister series anions (X): bromide, 
acetate, chloride, and iodide. Values were confirmed with 2-3 independent experiments. G+ = Gram-




hydrophobic tail residues, which have been shown to have a strong effect on antibacterial 
activity. Therefore, it is likely that several aspects of structure contribute to the overall 
antibacterial activity of these amphiphiles, and the ideal combination of head group, tail 
length, counterion, etc. may differ depending on different attributes of the bacteria such 
as membrane structure (Lo Nostro et al. 2005). 
Continued research is necessary to fully understand how counterion exchange 
affects the antibacterial activity of these amphiphiles. Although a clear trend was not 
observed, chloride and iodide may have promise as counterions for future compounds, 
especially those intended for use against P. aeruginosa. Further study of these effects is 
necessary to fully understanding the mechanisms of this change in antibacterial activity, 
as it is possible that counterion exchange with chloride and iodide may influence other 
aspects of antibacterial activity, such as biofilm disruption.  
3.3 Methods. 
Synthesis of M-1,1 
Preparation of M-1,1 was completed with a 1:1.8 molar equivalence of 1,3,5-
Trisbromomeythylbenzene (0.0056mol, 350mL)  to trimethylamine (0.01009mol, 
150mL) in acetone. Both solutions are chilled on ice for 15min. After chilling, the 
trimethylamine solution was added drop wise to the 1,3,5-Trisbromomeythylbenzene 
solution overnight, while on ice. The product of the reaction was then filtered and 
recrystallized using a 100:3 solution of acetone to ethanol (100mL per 27mg M-1,1). 







Synthesis of M-1,1,18 
Preparation of M-1,1,18 was completed using a 1:1.5 mole ratio of M-1,1 to 
dimethyl-octadecylamine respectively. The reaction was completed in ethanol and left at 
80°C under reflux overnight. The product was dried under N2 gas, re-suspended in 
acetone, and filtered. The resulting solid was recrystallized using ethanol and acetone. 
Synthesis of the product was confirmed using 
1
HNMR. 
Counterion exchange of M-1,1,18 
Monovalent counter ion exchange was done with a 1:3.6 molar equivalence of M-








). While divalent 
counter ion exchange was done with a 1:1.8 molar equivalence of M-1,1,18 to the 
corresponding Ag2X salt (X=CO3
2-
). The reaction was done in methanol (45mL per 
250mg M-1,1,18), stirring overnight under light free conditions. The resulting product 
was filtered through a celite packed filter and rinsed with 50 mL of excess methanol. The 
filtrate was rotovapped down at temperatures below 50˚C.  The resulting solid was 
resuspended in 5mL methanol and centrifuged for 3min. A small partition of the 
supernatant was combined with AgNO3
-
 and the resulting precipitate was tested on the 
PXRD. The absence of major peaks at 31 and 44.3 indicated that no remaining AgBr was 
present in solution. The supernatant was then rotovapped down and the resulting solid 
was put in the desiccator with P2O5 to remove any water present. The presence of the 
correct ion exchanged compound was confirmed via HRMS and 
1
HNMR.  




A conductivity probe was used to measure the critical aggregate concentration of 
the amphiphile. The solution was heated to 37°C. The probe was mixed in the solution 
and the measurements were collected. Ten percent of the current solution was pipetted 
out and replaced with nanopure water. The solution was mixed and the conductivity 
measurement recorded. These steps were repeated for the entirety of the experiment.  
Bacterial strains and growth conditions 
The two Gram-negative bacterial strains used were Escherichia coli ATCC® 
25922™ and Pseudomonas aeruginosa ATCC® 27853™, and the five Gram-positive 
bacterial strains used in this study were Staphylococcus aureus subsp. aureus ATCC® 
29213™, Enterococcus faecalis ATCC® 29212™, Bacillus subtilis, B. anthracis Sterne, 
and Streptococcus agalactiae J48 (Seifert et al. 2006). All strains were grown in 1X 
Mueller-Hinton Broth at 37° C for 12–24 h. For the MIC studies, bacterial suspensions 
were prepared by diluting overnight cultures to 5x106 CFU/mL in 2X Mueller-Hinton 
Broth, so that when amphiphile solutions were added the final broth strength was 1X. 
Minimum inhibitory concentration 
 The methods used to determine the MIC were performed as previously described 
(Ladow et al. 2011; CLSI, 2012). Briefly, compounds were serially diluted in sterile 
dionized water and 100µL of each dilution were added to the wells of a 96-well flat-
bottomed microtiter plate in triplicate. After adding 100µL of the bacterial cell 
suspension (5x10
6
 CFU/mL), the plates were incubated at 37°C for 72 h. The MIC of the 
compound was defined as the minimum concentration that resulted in visible inhibition of 




Chapter 4: The effect of spacer variation on the antibacterial activity of bis- and 
tetra-cationic double-tailed amphiphiles. 
4.1 Introduction. 
The relative size of the hydrophobic region of QACs relative to the hydrophilic 
region is one of the greatest predictors of membrane permeability and antibacterial 
activity (Paniak et al. 2014). While changing the length of the hydrocarbon tails alters the 
size of the hydrophobic region relative to the charged head group and alter characteristics 
of membrane insertion activity, this effect may also be achieved by changing the way the 
hydrocarbon tails are positioned on the central ring of the amphiphile. It is therefore 
possible that changing the number of carbons separating two symmetrical hydrocarbon 
tails on a central Mesitylene ring may affect antibacterial activity. 
Three series of bis-cationic amphiphiles and three series of tetra-catioic 
amphiphiles were synthesized in order to determine differences in the orientation of the 
hydrocarbon tails relative to one another on the central ring affects antibacterial activity. 
The bis-cationic amphiphiles included one series with the symmetrical tails in an ortho 
orientation (oX-n,n), one series with the tails in a meta orientation (mX-n,n), and one 
series with the tails in a para orientation (pX-n,n; Figure 7).  The oX-n,n series included 
four tail length derivatives ranging from 8 to 14 carbons per tail. The mX-n,n series 
included three tail length derivatives ranging from 8 to 12 carbons per tail, and the pX-
n,n series included five derivatives ranging from 8 to 16 carbons per tail.  
Tetra-cationic amphiphiles each had two head groups, each containing two 
dimethylammonium residues separated by a chain of two carbons. Each head group had a 




from 8-12 carbons for each of the three series: oX-(2,n)2, . mX-(2,n)2, and pX-(2,n)2 
(Figure 8).  
Additionally, one series of three triple-tailed amphiphiles was also tested for its 
antibacterial activity. The M-(2,n)3 series consists of amphiphiles with six positive 




3.2 Results and Discussion. 
The antibacterial activity of the bis-cationic series of amphiphiles followed the same 
trend as previous amphiphile series according to tail length, with 12 carbon derivatives 
having the lowest MIC values (Table 5, Figure 15). This trend was seen for all three 
series, suggesting that, similar to series with changes in head group discussed in Chapter 
1, the length of the hydrocarbon tails is the most accurate predictor of antibacterial 
activity. Changing the spacer length between the tails on the central ring did not appear to 
have a significant effect on which hydrocarbon tail length was most effective.  
The 12-carbon derivatives of the bis-cationic series had broad-spectrum 
antibacterial activity against both Gram-positive and Gram-negative bacteria. 
Interestingly, oX-12,12 had the highest level of bacteriocidal activity against P. 
aeruginosa, with an MIC of 2 μM, two- to four-fold lower than that of the Gram-positive 
species tested. pX-12,12 had an MIC of 2-4 μM against Gram-positive bacteria, and 4 
μM against both P. aeruginosa and E. coli (Table 5).  
Compound 















oX-8,8 >250 250 125 250 >250  250 
oX-10,10 31 16 4 16 8 16 16 
oX-12,12 2 4 8 8 4 8 4 
oX-14,14 31 63 8 63 4 16 4 
mX-8,8 250 >250 >250 >250 125 >250 125 
mX-10,10 31 16 16 16 16 8 4 
mX-12,12 8 8 8 8 8 4 4 
pX-8,8 >250 >250 >250 >250 250 250 250 
pX-10,10 8 16 8 8 8 8 8 
pX-12,12 4 4 2 2 2 4 4 
pX-14,14 31 31 16 31 16 4 8 
pX-16,16 250 125 250  31 31 63 
Table 5. Antibacterial activity of bis-cationic compounds in the oX-n,n, mX-n,n, and pX-n,n series with 
different hydrocarbon tail lengths. oX = ortho orientation; mX = meta orientation; pX = para orientation 





Figure 15. Antibacterial activity against seven bacterial species of bis-cationic compounds in the oX-n,n 
(diamonds), mX-n,n (squares), and pX-n,n (triangles) series with different hydrocarbon tail lengths. G- = 
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 Three series of tetra-cationic amphiphiles were also evaluated for their 
antibacterial activity (MIC) at three different hydrocarbon tail lengths for three spacer 
sizes (ortho, meta, and para orientation). For the compounds with the tails in the meta 
and para orientations, the same trend was observed as the bis-cationic amphiphiles 
discussed earlier. Compounds with the ideal 12 carbon chain length had the lowest MIC 
values compared to other tail lengths in the series. However, for tetra-cationic 
amphiphiles with the tails in the ortho orientation relative to one another, 8 hydrocarbons 
per tail appeared to be the most effective, with oX-(2,8)2 having the lowest MIC values (4 
μM against Gram-negative bacteria, and 2 μM against Gram-positive bacteria) compared 
to oX-(2,10)2 and oX-(2,12)2 (Table 6, Figure 16).   
Compound 















oX-(2,8)2 4 4 2 2 2 2 2 
oX-(2,10)2 125 31 16 16 4 2 4 
oX-(2,12)2 250 63 250 125 250 125 250 
mX-(2,8)2 >250 >250 250 >250 250 >250 125 
mX-(2,10)2 16 16 16 16 4 4 4 
mX-(2,12)2 8 8 2 2 4 4 4 
pX-(2,8)2 >250 250 250 250 250 >250 125 
pX-(2,10)2 16 16 16 16 4 4 4 
pX-(2,12)2 16 4 2 2 4 4 4 
Table 6. Antibacterial activity of tetra-cationic compounds in the oX-(2,n)2, mX-(2,n)2, and pX-(2,n)2 
series with different hydrocarbon tail lengths. oX = ortho orientation; mX = meta orientation; pX = para 





Figure 16. Antibacterial activity against seven bacterial species of tetra-cationic compounds in the oX-
(2,n)2 (diamonds), mX-(2,n)2 (squares), and pX-(2,n)2 (triangles) series with different hydrocarbon tail 













































































































A single triple-tailed series, M-(2,n)3, was also tested for its antibacterial activity. 
This series of compounds contains six positive charges and three tails of equal length, 
each with 8, 10, or 12 carbons. The compound with 10 carbons per tail (M-[2,10]3) had 
the lowest MIC values of any of the three derivatives (Table 7. Figure 17). Similar to the 
trend observed for the tetra-cationic oX-(2,n)2 series, the ideal tail length for the M-(2,n)3 
series was not 12 carbons, as it was for the majority of the other compounds tested. The 
8-carbon and 12-carbon tail length derivatives of this series both had higher MIC values 


























M-(2,8)3 16 16 16 1 4 4 2 
M-(2,10)3 8 2 2 1 1 4 1 
M-(2,12)3 16 31 2 4 8 4 4 
Table 7. Antibacterial activity of the triple-tailed M-(2,n)3 series. n = the number of carbons per tail. G- = 




























Figure 17. Antibacterial activity of compounds in the M-(2,n)3 series with different 




The MIC of M-(2,10)3 was notably as low as 1 μM against several Gram-positive 
species, including S. aureus, and was as low as 2 μM against the Gram-negative E. coli 
and 8 μM against P. aeruginosa (Table 7). These MIC values are comparable to the MIC 
values of 12-carbon derivatives of the double-tailed, triscationic series studied previously.  
These data taken together suggest that the ideal length of the hydrocarbon tails of 
these amphiphiles may change depending on other structural characteristics. Changes in 
the distribution of charge within the head group of these molecules likely affect 
electrostatic interactions between the amphiphiles and the largely negative lipid 
membrane of bacteria. Because electrostatic interactions and hydrophobic interactions 
both contribute to the overall antimicrobial mechanism of action (Ramos et al. 2007), 
changing the distribution of charge in relation to the size of the hydrophobic region may 
have significant effects on the ability of these molecules to insert into the membrane. 
Because the oX-(2,n)2 series has four positive residues compared to two in the oX-(n,n) 
series, this effect may be more pronounced, resulting in the change in the ideal size of the 
hydrophobic tails for insertion into the bacterial membrane.  
3.3 Methods.  
Bacterial strains and growth conditions. 








, and the five Gram-positive 









, Bacillus subtilis, B. anthracis Sterne, 




Mueller-Hinton Broth at 37° C for 12–24 h. For the MIC studies, bacterial suspensions 
were prepared by diluting overnight cultures to 5x10
6
 CFU/mL in 2X Mueller-Hinton 
Broth, so that when amphiphile solutions were added the final broth strength was1X. 
Minimum inhibitory concentration. 
The methods used to determine the MIC were performed as previously described
 
(Ladow et al. 2011; CLSI, 2012). Briefly, compounds were serially diluted in sterile 
dionized water and 100µL of each dilution were added to the wells of a 96-well flat-
bottomed microtiter plate in triplicate. After adding 100µL of the bacterial cell 
suspension (5x10
6
 CFU/mL), the plates were incubated at 37°C for 72 h. The MIC of the 







Chapter 5: Conclusions and Future Research. 
5.1 Conclusions 
 The minimum inhibitory concentration was determined for all amphiphiles 
against two Gram-negative and five Gram-positive organisms. Tail length affects 
antibacterial activity, with one tail length being optimal for each series. Consistent with 
previous studies (Marafino et al. 2015), compounds with twelve carbons in each of two 
symmetrical hydrocarbon tails are the most effective, compared to compounds with 
longer or shorter tails. This trend was observed for four different amphiphile series, each 
with a differently substituted third head group residue, suggesting that head group 
substitution does not have as large of an effect on antibacterial activity as tail length, 
provided that the head group residues are of comparable size and charge. 
 All of the amphiphiles tested (M-E,12,12; M-DMAP,12,12; M-IQ,1212; and M-
4PP,12,12) were capable of disrupting established biofilm. Despite having MIC values as 
low as 4-8 µM, significant biofilm disruption was only observed at much higher 
concentrations, approximately 31-63 µM. This was unsurprising, considering the fact that 
bacteria in biofilms tend to be highly resistant to antibiotics and biocides (Lewis, 2001). 
M-E,12,12; M-DMAP,12,12; and M-IQ,12,12 were able to disrupt a similar amount of 
established P. aeruginosa biofilm as the antibiotic tobramycin at comparable 
concentrations. The amphiphile M-4PP,12,12 disrupted a similar amount of biofilm as 
benzalkonium chloride at comparable concentrations, though the amount of biofilm 
removed by M-4PP,12,12 was lower than that removed by the other 12-carbon derivative 
compounds tested. Due to their ability to remove established biofilms, these compounds 




antimicrobial agents. Further research is necessary to determine the exact mechanism of 
action of biofilm removal, and what aspects of amphiphile structure are most important 
for variations in anti-biofilm activity. 
 Different counterions also affect antibacterial activity. Substitution of bromide 
with different ions from the Hofmeister series led to changes in MIC, particularly against 
P. aeruginosa. The single-tailed amphiphile M-1,1,18 and the double-tailed amphiphile 
M-1,12,12 were more effective at inhibiting the growth of P. aeruginosa with chloride 
and iodide counterions than with bromide. Other counterions such as acetate, carbonate, 
and nitrate had little effect, or even increased the MIC for these amphiphiles. Despite 
notable differences in the MIC for amphiphiles paired with different Hofmeister 
counterions, no clear trend was observed between the MIC and any chemical attributes of 
the Hofmeister series itself. Although use of different counterions such as chloride and 
iodide appear to have potential to increase the efficacy of charged cationic antimicrobials, 
particularly against Gram-negative pathogens such as P. aeruginosa, more research is 
needed to determine the mechanism by which these different counterions increase the 
efficacy of quaternary ammonium amphiphiles. 
 Finally, the orientation of tails relative to each other on the mesitylene core of 
tetra-cationic amphiphiles also has an effect on the optimal tail length. The amphiphiles 
with tails in the para or meta orientation on the central ring followed a similar trend to 
the tris-cationic double-tailed amphiphiles, with 12 carbons being the ideal length per tail 
for the most efficient antibacterial activity. However, amphiphiles with the two tails in 




No shift in the optimal tail length was observed for the bis-cationic amphiphiles. 
Bis-cationic amphiphiles with the two tails in the ortho, meta, and para orientation, all 
had an ideal tail length of 12 carbons per tail.  
The shift in optimal tail length specific to tetra-cationic amphiphiles bears further 
study, particularly the possibility that compounds in the oX-(2,n)2 series with shorter 
hydrocarbon tails may have even more efficient antibacterial activity. If 8 carbons is 
indeed the ideal tail length for amphiphiles in this series, then it is more likely that the 
MIC will increase with shorter tail lengths, similar to the trend observed for previously 
tested compounds, whose ideal tail length is 12 carbons per tail.  
All of these data can be used to synthesize more effective compounds in the 
future. Understanding effects of tail length, counterion, and charge distribution on 
antibacterial activity, biofilm disruption, and cytotoxicity will be useful for developing 
amphiphilic compounds that may serve as novel antibiotics or disinfectants. The 
development of novel compounds is essential to prevent the spread of resistant infections 
in the population, particularly in people with compromised immune systems, such as the 





5.2 Future Reseach 
10-14-AO – Fluorescent Compound 
 The fluorescent compound 10-14-AO was derived from acridine orange. A 50 μM 
solution of 10-14-AO was incubated at room temperature for one hour with an overnight 
liquid culture of Streptococcus agalactiae and visualized using a 60X objective on a 
confocal microscope.  
 
 The compound 10-14-AO was 
successfully taken up into the bacterial cells 
and fluoresced at approximately 540 nm, 
allowing for the visualization of intact S. 
agalactiae cells (Figure 18, Figure 19). This 
compound may have applications in the 
determination of mechanism of action, or in 
the study of the movement of amphiphiles 

















Figure 19. S. agalactiae incubated with 
fluorescent compound 10-14-AO, visualized 
at 60X magnification using confocal 
microscopy. 
Figure 18. Excitation and emission 
spectra for 10-14-AO. Excitation 
was determined by irradiating the 
sample with light from 400-520 nm 
and monitoring emitted light at 531 
nm. Emission was determined by 
irradiating the sample with light at 
493 nm and monitoring emitted 




antibacterial activity of this compound has yet to be determined, and further studies will 
determine the effects of structural changes on fluorescence and uptake into the cells, as 
well as biofilm penetration.  
Activity against other E.S.K.A.P.E. pathogens 
 E.S.K.A.P.E. pathogens refer to the most relevant antibiotic-resistant bacteria 
(Enterococcus faecium, S. aureus, Klebsiella pneumoniae, Acinetobacteri baumanii, P. 
aeruginosa, and Enterobacter species; Rice, 2008). Because of their promising level of 
activity against prominent pathogens such as P. aeruginosa and S. aureus, these 
amphiphiles should be tested for their ability to kill other as-yet-untested pathogenic 
bacteria such as Acinetobacter baumannii and Klebsiella pneumoniae. While these 
pathogens pose little risk to healthy people, they are common causes of healthcare-
associated wound and bloodstream infection, and are often resistant to many commonly 
used antibiotics (CDC, 2010; 2015). K. pneumoniae, in particular, has been implicated in 
the increasing spread of carbapenem-resistant Enterobacteriaceae (CRE) due to its ability 
to produce a potent carbapenemase (CDC, 2015). Due to their broad spectrum of activity 
against Gram-negative and Gram-positive pathogens notorious for having high levels of 
resistance to antibacterial compounds, the compounds presented in this study may also be 
effective against K. pneumoniae and A. baumannii, presenting an opportunity for the 
development of new compounds to prevent the spread of these and other prominent 






Mechanism of action 
 Given ample previous research into the mechanism of action of amphiphilc AMPs 
and structurally similar amphiphiles, it is likely that these compounds are membrane-
active, causing depolarization and lysis of bacterial cells (Dathe and Wieprecht, 1999; 
Thiyagarajan et al. 2014; Goswami et al. 2015). Propidium iodide permeability assays 
can be used in order to gain more information about the membrane-permeabilizing 
activity of these compounds (Rieger et al. 2011). Further studies to determine the biofilm 
disruption mechanism will be explored such as fluorescence microscopy. 
Cytotoxicity 
 Because the mode of action of these compounds is likely membrane 
permeabilization, depolarization and lysis, it is possible that these amphiphiles may not 
be compatible with human cells. The cytotoxicity of amphiphiles is largely structure-
dependent, with some amphiphiles having cytotoxic concentrations many times higher 
than the MIC (Goswami et al. 2015). It is also possible that fundamental differences 
between the mammalian and bacterial cell membranes may increase the therapeutic 
potential of these compounds. Namely, unlike the net negatively charged bacterial 
membrane, the outer leaflet of the mammalian plasma membrane is neutral, with 
negatively charged phospholipids largely localized to the cytosolic leaflet (Cooper, 
2000). This may decrease the effects of electrostatic interactions between cationic 
membrane-active compounds and the membrane by making hydrophobic interactions the 




through hemolysis assays and testing using epithelial cells is necessary to confirm the 
safety of these compounds for therapeutic use.  
Synergistic combinations and pre-treatment 
 Synergistic combinations of some similar amphiphiles have been observed in 
prior studies (Marafino et al. 2015). Of particular interest is the potential for synergy 
between antibacterial amphiphiles and sodium metaperiodate (NaIO4), which is used to 
disrupt extracellular polysaccharides, particularly against established biofilms (Gawande 
et al. 2007; Gutiérrez et al. 2013). Since these compounds likely disrupt bacterial biofilms 
by infiltrating the matrix and lysing cells within the biofilm, without disrupting the matrix 
itself directly, pre-treatment or co-incubation with NaIO4 may increase the biofilm 
disruption ability of QACs. 
 Some research also suggests that synergistic interactions with conventional 
antibiotics may increase bactericidal activity. Membrane permeabilizing agents have been 
used with antibiotics such as erythromycin in order to make Gram-negative bacteria 
susceptible to otherwise ineffective treatments by breaking down their outer membrane 
(Goswami et al. 2015). Similar studies to characterize any synergistic combinations of 
these compounds and a variety of antibiotics could further characterize the method of 
action of the compounds being studied, as well as provide a proof of concept for these 
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